Are Head-to-Head Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy Really Necessary for Localized Hepatocellular Carcinoma?

Affiliations

¹ Naoko Sanuki, Mie Prefectural General Medical Center, Yokkaichi, and Ofuha Chuo Hospital, Kamakura, Japan; and Atsuya Takeda, Ofuna Chuo Hospital, Kamakura, Japan.

Comment

Naoko Sanuki et al. J Clin Oncol. 2018.

. 2018 Aug 20;36(24):2563-2564.

doi: 10.1200/JCO.2018.78.2805. Epub 2018 Jun 26.

¹ Naoko Sanuki, Mie Prefectural General Medical Center, Yokkaichi, and Ofuha Chuo Hospital, Kamakura, Japan; and Atsuya Takeda, Ofuna Chuo Hospital, Kamakura, Japan.

No abstract available

Comment in

Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et al.
Rajyaguru DJ, Borgert AJ, Halfdanarson TR, Truty MJ, Kurup AN, Go RS. Rajyaguru DJ, et al. J Clin Oncol. 2018 Aug 20;36(24):2567-2569. doi: 10.1200/JCO.2018.78.6418. Epub 2018 Jun 26. J Clin Oncol. 2018. PMID: 29945519 No abstract available.

Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.
Rajyaguru DJ, Borgert AJ, Smith AL, Thomes RM, Conway PD, Halfdanarson TR, Truty MJ, Kurup AN, Go RS. Rajyaguru DJ, et al. J Clin Oncol. 2018 Feb 20;36(6):600-608. doi: 10.1200/JCO.2017.75.3228. Epub 2018 Jan 12. J Clin Oncol. 2018. PMID: 29328861